Aimmune Therapeutics
A clinical stage biopharmaceutical company focused on food allergies
Based in CA
AI Overview
With $510K in lobbying spend across 9 quarterly filings, Aimmune Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2019 to 2020.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $270K |
| 2020 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Aimmune Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to the treatment of food allergies
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.